SEC Form 4 · accession 0001638599-18-000589
SELECTA BIOSCIENCES INC · SELB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Omid Farokhzad
Director
Period of report
May 30, 2018
Accepted (ET)
Jun 1, 2018 · 7:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453687
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $12.02 | May 30, 2018 | A | 95,000 | A | — | May 29, 2028 | Common Stock | 95,000 | 95,000 | D |
Explanation of responses
- F1The option will vest as to 25% of the shares on May 30, 2019. The remainder of the shares will vest in 36 equal monthly installments thereafter.